[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335460-105":59,"doc-detail-335460-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","elevated-expression-levels-of-the-protein-kinase-dyrk1b-induce-mesenchymal-features-in-a549-lung-cancer-cells","Elevated expression levels of the protein kinase DYRK1B induce mesenchymal features in A549 lung cancer cells","","Protein kinase DYRK1B acts as a negative regulator of cell proliferation, yet is frequently overexpressed across human solid cancers. The study addresses how increased DYRK1B levels influence cancer-cell behavior, using a conditional DYRK1B overexpression model in A549 lung adenocarcinoma cells to analyze gene-expression changes and associated phenotypic and functional outcomes. Induced DYRK1B promotes mesenchymal morphology, EMT-related transcriptional programs, and enhanced migratory capacity.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/elevated-expression-levels-of-the-protein-kinase-dyrk1b-induce-mesenchymal-features-in-a549-lung-cancer-cells/335460/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/elevated-expression-levels-of-the-protein-kinase-dyrk1b-induce-mesenchymal-features-in-a549-lung-cancer-cells/335460.png","ImageObject",300,407,{"name":92,"@type":93},"Skyler","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why study DYRK1B in cancer cells?","Question",{"text":112,"@type":113},"DYRK1B is overexpressed in many solid tumors, but the consequences of elevated DYRK1B levels for cancer-cell behavior were largely unclear. The study investigates how increased DYRK1B affects gene expression and phenotypes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the effect of DYRK1B tested in A549 cells?",{"text":117,"@type":113},"A549 lung adenocarcinoma cells were engineered with conditional overexpression of DYRK1B. The system was used to measure gene-expression changes and phenotypic or functional outcomes, including migration.",{"name":119,"@type":110,"acceptedAnswer":120},"What happens to A549 cells when DYRK1B is overexpressed?",{"text":121,"@type":113},"Induced wild-type DYRK1B drives mesenchymal morphology, reduces cell-cell contacts, and reorganizes pericellular actin into stress fibers. It is linked to increased SNAIL and SLUG expression and higher EMT-associated transcriptional changes, enhancing migratory capacity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335460,1790143969,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Sester etal. BMC Cancer (2024) 24:1341 BMC Cancer  \n[https://doi.org/10.1186/s12885-024-13057-0](https://doi.org/10.1186/s12885-024-13057-0)  \nRESEARCH Open Access  \nElevated expression levels of the protein kinase DYRK1B induce mesenchymal features in A549 lung cancer cells  \nSoraya Sester 1, Gerrit Wilms 1, Joana Ahlburg2, Aaron Babendreyer3 and Walter Becker 1*  \nAbstract  \nBackground The protein kinase DYRK1B is a negative regulator of cell proliferation but has been found to be overexpressed in diverse human solid cancers. While DYRK1B is recognized to promote cell survival and adaption to stressful conditions, the consequences of elevated DYRK1B levels in cancer cells are largely uncharted.  \nMethods To elucidate the role of DYRK1B in cancer cells, we established a A549 lung adenocarcinoma cell model featuring conditional overexpression of DYRK1B. This system was used to characterize the impact of heightened DYRK1B level s on gene expression and to monitor phenotypic and functional changes.  \nResults A549 cells with induced overexpression of wild type DYRK1B acquired a mesenchymal cell morphology with diminished cell-cell contacts and a reorganization of the pericellular actin cytoskeleton into stress fibers. This transition was not observed in cells overexpressing a catalytically impaired DYRK1B variant. The phenotypic changes were associated with increased expression of the transcription factors SNAIL and SLUG, which are core regulators of epithelial mesenchymal transition (EMT) . Further profiling of DYRK1B-overexpressing cells revealed transcriptional changes that are characteristic for the mesenchymal conversion of epithelial cells, including the upregulation of genes that are related to cancer cell invasion and metastasis. Functionally, DYRK1B overexpression enhanced the migratory capacity of A549 cells in a wound healing assay.  \nConclusions The present data identify DYRK1B as a regulator of phenotypic plasticity in A549 cells. Increased expression of DYRK1B induces mesenchymal traits in A549 lung adenocarcinoma cells.  \nKeywords DYRK1B, Protein kinase, A549, Lung adenocarcinoma, Phenotypic plasticity, Cancer cell migration, Stress fibers  \n*Correspondence:  \nWalter Becker  \n[wbecker@ukaachen.de](wbecker@ukaachen.de)  \n1Institute of Pharmacology and Toxicology, RWTH Aachen University, Aachen, Germany  \n2Institute of Molecular and Cellular Anatomy, RWTH Aachen University, Aachen, Germany  \n3Institute of Molecular Pharmacology, RWTH Aachen University, Aachen, Germany  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/.  \nSester et al. BMC Cancer (2024) 24:1341  \nIntroduction  \nDual specificity tyrosine phosphorylation-regulated kinase (DYRK) 1A and DYRK1B function as key regulators of cell division and differentiation [1–3]. Both protein kinases suppress proliferation by controlling the S-phase checkpoint [4]. Besides cell cycle regulation, DYRK1A and DYRK1B modulate multiple cellular processes that are relevant to the onset and progression of human tumors, including DNA damage repair, cell survival in stress conditions, apoptosis, and the balance between differentiation and ste","cbCaimw2Y6KesOba","https://ap.wps.com/l/cbCaimw2Y6KesOba","pdf",3148311,15,"English","# Abstract\n# Introduction\n## DYRK family roles in cell cycle and differentiation\n## DYRK1B overexpression and tumor relevance\n## Mechanistic implications for quiescence and therapy resistance","[{\"question\":\"Why study DYRK1B in cancer cells?\",\"answer\":\"DYRK1B is overexpressed in many solid tumors, but the consequences of elevated DYRK1B levels for cancer-cell behavior were largely unclear. The study investigates how increased DYRK1B affects gene expression and phenotypes.\"},{\"question\":\"How was the effect of DYRK1B tested in A549 cells?\",\"answer\":\"A549 lung adenocarcinoma cells were engineered with conditional overexpression of DYRK1B. The system was used to measure gene-expression changes and phenotypic or functional outcomes, including migration.\"},{\"question\":\"What happens to A549 cells when DYRK1B is overexpressed?\",\"answer\":\"Induced wild-type DYRK1B drives mesenchymal morphology, reduces cell-cell contacts, and reorganizes pericellular actin into stress fibers. It is linked to increased SNAIL and SLUG expression and higher EMT-associated transcriptional changes, enhancing migratory capacity.\"}]","Elevated expression levels of the protein kinase DYRK1B induce mesenchymal features in A549 lung cancer cells | PDF",1790011056,38]